C
Caliva
Premier cannabis dispensary and cultivation facility in California
About Caliva
Caliva operates in the burgeoning cannabis industry, positioning itself as a trusted brand in the market. The company is vertically integrated, meaning it controls every step of the process, from growing the cannabis to selling it in their own dispensaries. This allows Caliva to ensure the quality and purity of their products, which are tested in-house at Caliva Labs.
Read full description
The company serves a diverse range of clients, from individual consumers to retailers and distributors. For consumers, Caliva offers a variety of cannabis strains, each selected for its superior effects and premier genetics. These products are available for purchase at their San Jose dispensary or can be ordered online for delivery.
For retailers and distributors, Caliva provides a reliable source of quality cannabis products. The company's vertical integration allows it to offer competitive pricing and consistent supply, making it an attractive partner for businesses in the cannabis industry.
Caliva's business model is centered around its commitment to quality and service. The company takes pride in guiding its customers, helping them find the right products to accommodate their needs and enhance their happiness. This focus on customer service, combined with the quality of its products, has helped Caliva build a strong brand in the cannabis market.
The company generates revenue through the sale of its cannabis products, both through its physical dispensary and its online store. The vertical integration of its operations allows Caliva to capture a larger share of the value chain, increasing its profitability.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Jose, United States
- Employees
- 134
- Open positions
- None listed
- Dealroom signal
- 34.1/100
- Industry
- Health, Food
- Sub-industry
- Pharmaceutical, AgriTech, Innovative Food
- Sector
- Biotech & Life Sciences, Wholesale, Biotechnology, Cannabis, Direct-to-Consumer, Biotech and Pharma, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning Caliva.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Jan 2019 | $75M | $300M | Joe Montana · Carol Bartz | ↗ |
| SEEDOther financing | Jul 2018 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Caliva is 670 monthly website visits, down 25.6% over the last three months. Caliva's team declined 2.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Joe Montana
Carol Bartz
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Caliva on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Caliva’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.